Rob Bryant

Rob Bryant

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Associate Professor Robert Bryant is Head of the Inflammatory Bowel Disease service at The Queen Elizabeth Hospital, Research Lead at the Basil Hetzel Institute, Chair of the Gastroenterology Network of Intestinal Ultrasound (GENIUS), a member of the GESA IBD Faculty, and Clinical Associate Professor at the University of Adelaide.

Rob undertook a Clinical Fellowship in Inflammatory Bowel Diseases (IBD) at the John Radcliffe Hospital in Oxford, after which he completed a Master of Science by Research (MScR) at the University of Oxford in the field of genetics and mucosal immunology in IBD. He thereafter completed a PhD at the University of Adelaide in the area of treatment targets in IBD, for which he was awarded a University Medal.

Rob leads the intestinal ultrasound service at TQEH and coordinates a clinical and translational research program exploring microbial therapy in IBD, both through diet and faecal microbial transplantation. He has been awarded the Michell McGrath Fellowship from The Hospital Research Foundation to pursue microbial manipulation in IBD.

  • Appointments
    Date Position Institution name
    2023 - ongoing Michell McGrath Fellow Basil Hetzel Institute
    2018 - ongoing Clinical Senior Lecturer University of Adelaide
    2017 - ongoing Staff Specialist Gastroenterologist, Head of Inflammatory Bowel Diseases Queen Elizabeth Hospital
    2016 - ongoing Basic Physician Training Clinical tutor and examiner Queen Elizabeth Hospital
    2016 - ongoing Clinical Lecturer, Medical School Lecture Series University of Adelaide
    2016 - 2016 Gastrointestinal Ultrasound Fellowship Sacco University Hospital
    2015 - 2018 Lecturer SAPMEA Postgraduate Medical Education Association lectures
    2015 - 2017 Consultant Gastroenterologist Royal Adelaide Hospital
    2015 - ongoing Visiting Medical Specialist Alice Springs Hospital
    2014 - 2015 Clinical Research Fellow University of Oxford
    2013 - 2015 Senior Clinical Fellow in Gastroenterology John Radcliffe Hospital
    2011 - 2013 Gastroenterology Advanced Trainee Royal Adelaide Hospital
    2011 - 2012 Academic and clinical tutor, Basic Physician Training Program Royal Adelaide Hospital
    2011 - 2012 Guest lecturer and bedside tutor University of Adelaide
    2008 - 2011 Basic Physician Trainee Royal Adelaide Hospital
    2007 - 2007 Resident Medical Officer Royal Hobart Hospital
    2006 - 2006 Internship Royal Perth Hospital

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2016 Scholarship AR Clarkson Scholarship Royal Adelaide Hospital Research Committee Australia -
    2012 Award Mark Jolly Foundation Fellowship Award Royal Adelaide Hospital Australia -
    2012 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia -
    2010 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia -
    2004 Award Meritous award for Geriatrics School of Medicine, University of Adelaide Azerbaijan -
    2004 Award Meritous Award for Obstetrics and Gynaecology School of Medicine, University of Adelaide Australia -

  • Education
    Date Institution name Country Title
    2015 - 2018 University of Adelaide Australia PhD
    2014 - 2015 University of Oxford United Kingdom Master of Science (by Research) MScR
    2005 University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery (MBBS)

  • Postgraduate Training
    Date Title Institution Country
    2014 - 2015 Master of Science by Research (MScR) University of Oxford United Kingdom
    2011 - 2013 Fellowship of the Royal Australasian College of Physicians (FRACP) Royal Australasian College of Physicians Australia

  • Research Interests
    Gastroenterology and Hepatology Nutrition and Dietetics

  • Journals
    Year Citation
    2024 Russell, E. E., Day, A. S., Dimitroff, C., Trakman, G. L., Silva, H., Bryant, R. V., . . . Fitzpatrick, J. A. (2024). Practical application of the Crohn's disease exclusion diet as therapy in an adult Australian population. Journal of Gastroenterology and Hepatology (Australia), 39(3), 446-456.
    DOI Scopus5 Europe PMC4
    2024 Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2024). Author reply to Hettiarachchi et al. (re Helicobacter pylori resistance in Australia…). Internal Medicine Journal, 54(2), 356-357.
    DOI
    2024 Lu, C., Rosentreter, R., Delisle, M., White, M., Parker, C., Premji, Z., . . . Rieder, F. (2024). Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary Pharmacology and Therapeutics, 59(8), 928-940.
    DOI Scopus9 Europe PMC5
    2024 Collins, M. G., Fahim, M. A., Hawley, C. M., Johnson, D. W., & Chadban, S. J. (2024). Questions about the BEST-Fluids trial - Authors' reply. The Lancet, 403(10430), 911-912.
    DOI Scopus1
    2024 Mathias, R. M., Chu, M. K. W., Edwards, S., Day, A. S., Ma, C., Jairath, V., & Bryant, R. V. (2024). Editorial: Sonographic assessment of colonic content-A new tool for constipation? Authors' reply.. Alimentary pharmacology & therapeutics, 60(2), 296-297.
    DOI
    2024 Melton, S. L., Day, A. S., Bryant, R. V., & Halmos, E. P. (2024). Revolution in diet therapy for inflammatory bowel disease. JGH Open, 8(7), 10 pages.
    DOI Scopus2
    2024 Bogatic, D., & Bryant, R. V. (2024). Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease—hope on the horizon. Alimentary Pharmacology and Therapeutics, 60(4), 535-536.
    DOI
    2024 Little, R. D., McKenzie, J., Srinivasan, A., Hilley, P., Gilmore, R. B., Chee, D., . . . Sparrow, M. P. (2024). Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial. BMJ Open, 14(7), 8 pages.
    DOI Europe PMC1
    2024 Mathias, R. M., & Bryant, R. V. (2024). Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 60(6), 833-834.
    DOI Scopus1
    2024 Day, A. S., Ballard, T. M., Yao, C. K., Gibson, P. R., & Bryant, R. (2024). Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes. INFLAMMATORY BOWEL DISEASES, 17 pages.
    DOI
    2024 Goodsall, T. M., An, Y. K., Andrews, J. M., Begun, J., Friedman, A. B., Lee, A., . . . Bryant, R. V. (2024). Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central Reading. Clinical Gastroenterology and Hepatology, S1542-3565(24)00773-0.
    DOI
    2024 Barnes, A., Bryant, R. V., Mukherjee, S., Spizzo, P., & Mountifield, R. (2024). Sleep quality is associated with reduced quality of life in inflammatory bowel disease through its interaction with pain. JGH Open, 8(8), 8 pages.
    DOI
    2024 Barnes, A., Bryant, R. V., Mukherjee, S., Andrews, J. M., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach. Therapeutic Advances in Gastroenterology, 17, 12 pages.
    DOI
    2024 Bogatic, D., & Bryant, R. V. (2024). Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post-operative recurrence of Crohn's disease. Alimentary Pharmacology and Therapeutics, 60(10), 1501-1502.
    DOI
    2024 Lu, C., Rosentreter, R., Parker, C. E., Remillard, J., Wilson, S. R., Baker, M. E., . . . Rieder, F. (2024). International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement. The Lancet Gastroenterology and Hepatology, 9(12), 1101-1110.
    DOI
    2024 Mathias, R. M., Plush, S. L., Fairhead, E. J. S., Ngoi, B., Edwards, L., Day, A. S., & Bryant, R. V. (2024). Patients with functional gastrointestinal disorders spend less time in tertiary care when managed by a single clinician: results of a multicentre audit in South Australia. Internal Medicine Journal, 10 pages.
    DOI
    2024 Gilmore, R., Fernandes, R., Hartley, I., Arzivian, A., Leong, R., Andrew, B., . . . Begun, J. (2024). Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.. Intestinal research.
    DOI
    2024 Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intestinal Research, 22(1), 104-114.
    DOI Scopus5 WoS1 Europe PMC4
    2024 Barnes, A., Toson, B., Bryant, R. V., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Latent profiles of fatigue in inflammatory bowel disease. BMC Gastroenterology, 24(1), 7 pages.
    DOI Europe PMC1
    2024 Touhara, K. K., Rossen, N. D., Deng, F., Chu, T., Harrington, A. M., Garcia Caraballo, S., . . . Julius, D. (2024). Crypt and Villus Enterochromaffin Cells are Distinct Stress Sensors in the Gut.. bioRxiv.
    DOI
    2024 Mathias, R. M., Chu, M. K. W., Edwards, S., Day, A. S., Ma, C., Jairath, V., & Bryant, R. V. (2024). Meta-analysis: Intestinal ultrasound to evaluate colonic contents and constipation. Alimentary Pharmacology and Therapeutics, 60(1), 6-16.
    DOI Scopus3
    2024 Guichon, P. A. M., Stone, J. R., & Thomas, A. W. (2024). Hartree-Fock formulation of the QMC model at finite temperature. Physical Review D: Particles, Fields, Gravitation and Cosmology, 109(8), 083035-1-083035-13.
    DOI Scopus2
    2024 Fussner, L. A., Flores-Suárez, L. F., Cartin-Ceba, R., Specks, U., Cox, P. G., Jayne, D. R. W., . . . Aniort, J. (2024). Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). American Journal of Respiratory and Critical Care Medicine, 209(9), 1141-1151.
    DOI Scopus4 Europe PMC3
    2023 Li, A., Bowen, J. M., Ball, I. A., Wilson, S., Yong, A., Yeung, D. T., . . . Wardill, H. R. (2023). Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study. Biomedicines, 11(12), 1-9.
    DOI Scopus1
    2023 Raja, S. S., Bryant, R. V., Costello, S. P., Barnett, M., Schubert, J., & Rayner, C. K. (2023). Systematic review of therapies for refractory ulcerative proctitis. Journal of Gastroenterology and Hepatology (Australia), 38(4), 496-509.
    DOI Scopus5 WoS2 Europe PMC1
    2023 Pudipeddi, A., Fung, C., Christensen, B., Bryant, R. V., Subramaniam, K., Chetwood, J., . . . Leong, R. W. (2023). Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists. World Journal of Gastroenterology, 29(2), 378-389.
    DOI Scopus4 WoS2 Europe PMC3
    2023 Tucker, E. C., Haylock-Jacobs, S., Rapaic, M., Dann, L. M., Bryant, R. V., & Costello, S. P. (2023). Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation. JGH Open, 7(3), 172-177.
    DOI Scopus4 WoS2 Europe PMC3
    2023 Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Spizzo, P., . . . Mountifield, R. (2023). Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease. Crohn's and Colitis 360, 5(2), 8 pages.
    DOI Scopus3 Europe PMC3
    2023 Bryant, R. V., & Travis, S. P. L. (2023). APOLLO Has Landed: PROMS and Histology in UC. Journal of Crohn's and Colitis, 17(7), 1027-1028.
    DOI
    2023 Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2023). Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance. Internal Medicine Journal, 53(11), 1972-1978.
    DOI Scopus4 Europe PMC1
    2023 St-Pierre, J., Delisle, M., Kheirkhahrahimabadi, H., Goodsall, T. M., Bryant, R. V., Christensen, B., . . . Novak, K. L. (2023). Bedside Intestinal Ultrasound Performed in an IBD Urgent Assessment Clinic Improves Clinical Decision Making and Resource Utilization. Crohn's & Colitis 360, 5(4), 1-9.
    DOI Scopus4 Europe PMC2
    2022 Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2022). Microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics, 57(1), 23-36.
    DOI Scopus6 Europe PMC4
    2022 Schubert, J. P., Rayner, C. K., Costello, S. P., Roberts-Thomson, I. C., Forster, S. C., & Bryant, R. V. (2022). Helicobacter pylori: Have potential benefits been overlooked?. JGH Open, 6(11), 735-737.
    DOI Scopus4 WoS1 Europe PMC2
    2022 Ilvemark, J. F. K. F., Hansen, T., Goodsall, T. M., Seidelin, J. B., Al- Farhan, H., Allocca, M., . . . Wilkens, R. (2022). Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement. Journal of Crohn's and Colitis, 16(4), 554-580.
    DOI Scopus67 WoS41 Europe PMC26
    2022 Kucharzik, T., Tielbeek, J., Carter, D., Taylor, S. A., Tolan, D., Wilkens, R., . . . Rimola, J. (2022). ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease. Journal of Crohn's and Colitis, 16(4), 523-543.
    DOI Scopus57 WoS16 Europe PMC28
    2022 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2022). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 35(1), 234-244.
    DOI Scopus24 WoS13 Europe PMC13
    2022 Santos-Paulo, S., Costello, S. P., Forster, S. C., Travis, S. P., & Bryant, R. V. (2022). The gut microbiota as a therapeutic target for obesity: A scoping review. Nutrition Research Reviews, 35(2), 207-220.
    DOI Scopus21 WoS11 Europe PMC12
    2022 Goodsall, T. M., & Bryant, R. V. (2022). Editorial: an accurate, reliable and responsive ultrasound activity score for Crohn’s disease? Sounds good to US. Alimentary Pharmacology and Therapeutics, 55(3), 360-361.
    DOI Scopus1 WoS1
    2022 Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Warner, M. S., Roberts-Thomson, I. C., . . . Bryant, R. V. (2022). Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?. Journal of gastroenterology and hepatology, 37(7), 1263-1274.
    DOI Scopus7 WoS4 Europe PMC4
    2022 Lee, S. Z., Schubert, J. P., Prowse, S. J. B., & Bryant, R. V. (2022). Are we underutilising computer tomography colonography in Australia?. Internal Medicine Journal, 52(5), 864-867.
    DOI Scopus2
    2022 Day, A. S., Yao, C. K., Costello, S. P., Ruszkiewicz, A., Andrews, J. M., Gibson, P. R., & Bryant, R. V. (2022). Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. Journal of Nutrition, 152(7), 1690-1701.
    DOI Scopus18 WoS8 Europe PMC12
    2022 Madsen, G. R., Wilkens, R., Boysen, T., Burisch, J., Bryant, R., Carter, D., . . . Tolsgaard, M. (2022). The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey. Alimentary Pharmacology and Therapeutics, 56(2), 263-270.
    DOI Scopus13 Europe PMC6
    2022 Duong, T. A., Bryant, R. V., Andrews, J. M., & Lynch, K. D. (2022). Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease. Internal Medicine Journal, 52(6), 1070-1074.
    DOI Scopus5 WoS4 Europe PMC2
    2022 Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., . . . Forster, S. C. (2022). Review article: the future of microbiome-based therapeutics. Alimentary Pharmacology and Therapeutics, 56(2), 192-208.
    DOI Scopus43 WoS7 Europe PMC20
    2022 Al-Ani, A. H., Vaughan, R., Christensen, B., Bryant, R. V., & Novak, K. L. (2022). Treat to transmural healing: how to incorporate intestinal ultrasound into the treatment of inflammatory bowel disease. British Journal of Radiology, 95(1137), 12 pages.
    DOI Scopus4 Europe PMC1
    2022 Ma, C., Hanzel, J., Panaccione, R., Sandborn, W. J., D'Haens, G. R., Ahuja, V., . . . Jairath, V. (2022). CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology, 163(4), 950-964.
    DOI Scopus46 WoS14 Europe PMC21
    2022 Soo, W. T., Costello, S. P., & Bryant, R. V. (2022). Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 67(1), 8-10.
    DOI Scopus2
    2021 Goodsall, T. M., Jairath, V., Bryant, R. V., & Ma, C. (2021). Editorial: use of intestinal ultrasound in the scoring of Crohn’s disease activity in clinical trials – is it ready for prime time yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 53(8), 948-949.
    DOI
    2021 Goodsall, T. M., Noy, R., Nguyen, T. M., Costello, S. P., Jairath, V., & Bryant, R. V. (2021). Systematic review: Patient perceptions of monitoring tools in inflammatory bowel disease. Journal of the Canadian Association of Gastroenterology, 4(2), E31-E41.
    DOI Scopus35 Europe PMC19
    2021 Goodsall, T. M., Han, S., & Bryant, R. V. (2021). Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. Journal of Gastroenterology and Hepatology (Australia), 36(6), 1550-1555.
    DOI Scopus15 WoS13 Europe PMC15
    2021 Schubert, J. P., Gehlert, J., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., Mangoni, A. A., & Bryant, R. V. (2021). Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis. Journal of gastroenterology and hepatology, 36(6), 1450-1456.
    DOI Scopus19 WoS10 Europe PMC13
    2021 Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3.
    DOI Scopus23 WoS11 Europe PMC9
    2021 Ma, C., Sedano, R., Almradi, A., Casteele, N. V., Parker, C. E., Guizzetti, L., . . . Jairath, V. (2021). An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials. Gastroenterology, 160(7), 2291-2302.
    DOI Scopus74 WoS25 Europe PMC38
    2021 Goodsall, T. M., Jairath, V., Feagan, B. G., Parker, C. E., Nguyen, T. M., Guizzetti, L., . . . Ma, C. (2021). Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Alimentary Pharmacology and Therapeutics, 53(8), 873-886.
    DOI Scopus48 WoS35 Europe PMC24
    2021 Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142.
    DOI Scopus57 WoS33 Europe PMC29
    2021 Bryant, R. V., Day, A. S., McGrath, K. C., Telfer, K., Yao, C. K., & Costello, S. P. (2021). Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis. JGH Open, 5(9), 1099-1102.
    DOI Scopus10 WoS5 Europe PMC4
    2021 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 16 pages.
    DOI Scopus41 WoS15 Europe PMC25
    2021 Prentice, R. E., Rentsch, C., Al-Ani, A. H., Zhang, E., Johnson, D., Halliday, J., . . . Christensen, B. (2021). SARS-CoV-2 vaccination in patients with inflammatory bowel disease.. GastroHep, 3(4), 212-228.
    DOI Europe PMC8
    2021 Schubert, J. P., Warner, M. S., Rayner, C. K., Roberts-Thomson, I., Mangoni, A. A., Costello, S., & Bryant, R. V. (2021). Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years. Internal Medicine Journal, 52(9), 1554-1560.
    DOI Scopus17 WoS6 Europe PMC9
    2021 Day, A. S., Wood, J. A., Halmos, E. P., & Bryant, R. V. (2021). Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. Journal of the Academy of Nutrition and Dietetics, 121(2), 201-209.
    DOI Scopus1 WoS1 Europe PMC1
    2021 Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.. Journal of Human Nutrition and Dietetics, 34(2), 420-428.
    DOI Scopus17 WoS12 Europe PMC11
    2020 Meyer, E. J., Mignone, E., Hade, A., Thiruvenkatarajan, V., Bryant, R. V., & Jesudason, D. (2020). Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.. Diabetes Care, 43(11), e181-e184.
    DOI Scopus23 WoS16 Europe PMC7
    2020 Aysha, A. -A., Rentsch, C., Prentice, R., Johnson, D., Bryant, R. V., Ward, M. G., . . . Christensen, B. (2020). Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.. Intern Med J, 50(7), 798-804.
    DOI Scopus12 WoS10 Europe PMC11
    2020 Vanlint, A. S., Kaazan, P., Kwok, M., Bryant, R. V., Ooi, M., Bak, N., & Costello, S. (2020). Lessons from practice Low attenuation lymphadenopathy on computed tomography leading to diagnosis of Whipple disease. Medical Journal of Australia, 213(4), 161-162.e1.
    DOI
    2020 Gill, M., Blacketer, C., Chitti, F., Telfer, K., Papanicolas, L., Dann, L. M., . . . Costello, S. P. (2020). Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH Open, 4(5), 950-957.
    DOI Scopus10 WoS7 Europe PMC4
    2020 Costello, S. P., Day, A., Yao, C. K., & Bryant, R. V. (2020). Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis.. BMJ Case Rep, 13(8), 3 pages.
    DOI Scopus18 WoS9 Europe PMC13
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough. Journal of Crohn's and Colitis, 14(10), 1341-1342.
    DOI Scopus3 WoS1 Europe PMC2
    2020 Day, A., Wood, J., Melton, S., & Bryant, R. (2020). Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open, 4(2), 260-266.
    DOI Scopus24 WoS18 Europe PMC14
    2020 Rajagopalan, A., Sathananthan, D., An, Y. K., Van De Ven, L., Martin, S., Fon, J., . . . Bryant, R. V. (2020). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open, 4(2), 267-272.
    DOI Scopus36 WoS20 Europe PMC20
    2020 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. V. (2020). Point-of-care gastrointestinal ultrasound in inflammatory bowel disease: An accurate alternative for disease monitoring. JGH Open, 4(2), 273-279.
    DOI Scopus15 WoS10 Europe PMC8
    2020 Costello, S. P., & Bryant, R. V. (2020). Editorial: faecal microbiota transplantation—the silver bullet for severe and fulminant Clostridioides difficile infection?. Alimentary Pharmacology and Therapeutics, 51(1), 180-181.
    DOI
    2020 Soo, W. T., Bryant, R. V., & Costello, S. P. (2020). Faecal microbiota transplantation: Indications, evidence and safety. Australian Prescriber, 43(2), 36-38.
    DOI Scopus3 WoS1 Europe PMC1
    2020 Flanagan, E., Wright, E. K., Begun, J., Bryant, R. V., An, Y. -K., Ross, A. L., . . . Bell, S. J. (2020). Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography.. Journal of Crohn's & colitis, 14(10), 1405-1412.
    DOI Scopus42 WoS23 Europe PMC21
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Coronavirus disease 2019 (COVID-19) and implications for thiopurine use.. Med J Aust, 212(10), 490-490.e1.
    DOI Scopus5 WoS4 Europe PMC5
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). ABC of topical therapy in inflammatory bowel disease. JGH Open, 4(4), 556-557.
    DOI Scopus2 WoS2 Europe PMC2
    2019 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600.
    DOI Scopus49 WoS38 Europe PMC33
    2019 Oakland, K., Kahan, B. C., Guizzetti, L., Martel, M., Bryant, R. V., Brahmania, M., . . . Jairath, V. (2019). Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology, 17(6), 1121.
    DOI Scopus33 WoS24 Europe PMC17
    2019 Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63.
    DOI
    2019 Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., . . . Andrews, J. M. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164.
    DOI Scopus630 WoS440 Europe PMC360
    2019 Costello, S., & Bryant, R. (2019). Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal, 49(2), 148-151.
    DOI Scopus11 WoS7 Europe PMC5
    2019 Wardill, H., Secombe, K., Bryant, R., Hazenberg, M. D., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740.
    DOI Scopus52 WoS36 Europe PMC32
    2019 Bryant, R. V., & Costello, S. P. (2019). Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Alimentary Pharmacology and Therapeutics, 50(1), 103-104.
    DOI Scopus2 WoS2 Europe PMC1
    2019 Biswas, S., Bryant, R. V., & Travis, S. (2019). Interfering with leukocyte trafficking in Crohn's disease. Best Practice and Research: Clinical Gastroenterology, 38-39, 8 pages.
    DOI Scopus21 WoS18 Europe PMC10
    2019 Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis.. JGH open : an open access journal of gastroenterology and hepatology, 3(4), 274-276.
    DOI Scopus16 WoS10 Europe PMC5
    2019 Liu, J., Andrews, J. M., Sammour, T., Bryant, R. V., Grafton, R., Simpson, E., . . . Nixon, C. (2019). Benefits of exclusive enteral nutrition in adults with complex active Crohn's disease: A case series of 13 consecutive patients. Crohn's and Colitis 360, 1(3), 1-7.
    DOI Scopus2 WoS1
    2018 Schwerd, T., Bryant, R., Pandey, S., Capitani, M., Meran, L., Cazier, J. -B., . . . Uhlig, H. (2018). NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.. Mucosal immunology, 11(2), 562-574.
    DOI Scopus72 WoS54 Europe PMC45
    2018 Bryant, R. V., Friedman, A. B., Wright, E. K., Taylor, K. M., Begun, J., Maconi, G., . . . Gibson, P. R. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: An underused resource with potential paradigm-changing application. Gut, 67(5), 973-985.
    DOI Scopus134 WoS97 Europe PMC52
    2018 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607.
    DOI Scopus36 WoS26 Europe PMC19
    2018 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17.
    DOI Scopus57 WoS44 Europe PMC29
    2017 Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632.
    DOI
    2017 Bryant, R. V., Prowse, S. J. B., Nguyen-Hoang, A., & Lewis, M. C. (2017). Gastrointestinal: Adenocarcinoma in ileal Crohn's disease: A devil in disguise. Journal of Gastroenterology and Hepatology (Australia), 32(9), 1535.
    DOI Scopus1 WoS1 Europe PMC1
    2017 Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053.
    DOI Scopus248 WoS192 Europe PMC120
    2017 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., MacOni, G., . . . Dietrich, C. (2017). How to perform gastrointestinal ultrasound: Anatomy and normal findings. World Journal of Gastroenterology, 23(38), 6931-6941.
    DOI Scopus67 WoS41 Europe PMC34
    2017 Bezzio, C., Bryant, R. V., Manes, G., Maconi, G., & Saibeni, S. (2017). New horizons in the imaging of perianal Crohn’s disease: transperineal ultrasonography. Expert Review of Gastroenterology and Hepatology, 11(6), 523-530.
    DOI Scopus14 WoS7 Europe PMC7
    2017 Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224.
    DOI Scopus215 WoS175 Europe PMC139
    2017 Guirgis, M., Wendt, E., Wang, L. M., Walsh, A., Burger, D., Bryant, R. V., . . . Keshav, S. (2017). Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis, 11(4), jjw174.
    DOI Scopus13 WoS11 Europe PMC3
    2016 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., Maconi, G., . . . Dietrich, C. (2016). WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound in Medicine and Biology, 42(12), 2732-2742.
    DOI Scopus58 WoS39 Europe PMC29
    2016 Bryant, R. V., Burger, D. C., Delo, J., Walsh, A. J., Thomas, S., Von Herbay, A., . . . Travis, S. P. L. (2016). Beyond endoscopic mucosal healing in UC: Histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut, 65(3), 408-414.
    DOI Scopus322 WoS275 Europe PMC184
    2016 Bennett, A. L., Moore, D., Bampton, P. A., Bryant, R. V., & Andrews, J. M. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620.
    DOI Scopus32 WoS29 Europe PMC19
    2016 Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513.
    DOI Scopus21 WoS15 Europe PMC13
    2016 Walsh, A., Bryant, R., & Travis, S. (2016). Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology and Hepatology, 13(10), 567-579.
    DOI Scopus169 WoS139 Europe PMC91
    2016 Griffiths, E., McDonald, C., Bryant, R., Devitt, P., Bright, T., Holloway, R., & Thompson, S. (2016). Retrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleeding. ANZ Journal of Surgery, 86(5), 381-385.
    DOI Scopus10 WoS8 Europe PMC7
    2015 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906.
    DOI Scopus113 WoS92 Europe PMC68
    2015 Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305.
    DOI Scopus1 WoS1 Europe PMC1
    2015 Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328.
    DOI Scopus1 WoS1 Europe PMC1
    2015 Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., . . . Colombel, J. F. (2015). Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 110(9), 1324-1338.
    DOI Scopus1476 WoS1186 Europe PMC813
    2015 Bryant, R. V., Brain, O., & Travis, S. P. L. (2015). Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 50(1), 90-112.
    DOI Scopus60 WoS47 Europe PMC35
    2015 Bryant, R. V., Sandborn, W. J., & Travis, S. P. L. (2015). Introducing vedolizumab to clinical practice: Who, when, and how?. Journal of Crohn's and Colitis, 9(4), 356-366.
    DOI Scopus51 WoS40 Europe PMC37
    2015 Bryant, R. V., Winer, S., Travis, S. P. L., & Riddell, R. H. (2015). Response to Villanacci et. al. Journal of Crohn's & colitis, 9(5), 429.
    DOI
    2014 Bryant, R. V., Winer, S., SPL, T., & Riddell, R. H. (2014). Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn's and Colitis, 8(12), 1582-1597.
    DOI Scopus234 WoS206 Europe PMC146
    2014 Bryant, R., Jairath, V., Curry, N., & Travis, S. (2014). Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?. Journal of Crohn's and Colitis, 8(2), 166-171.
    DOI Scopus27 WoS22 Europe PMC14
    2013 Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225.
    DOI Scopus146 WoS116 Europe PMC88
    2013 Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176.
    DOI Scopus5 WoS3 Europe PMC4
    2013 Bryant, R., Kuo, P., Williamson, K., Yam, C., Schoeman, M., Holloway, R., & Nguyen, Q. (2013). Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointestinal Endoscopy, 78(4), 576-583.
    DOI Scopus98 WoS80 Europe PMC62
    2013 Bryant, R., Schoeman, S., & Schoeman, M. (2013). Shorter preparation to procedure interval for colonoscopy improves quality of bowel cleansing. Internal Medicine Journal, 43(2), 162-168.
    DOI Scopus19 WoS18 Europe PMC14
    2012 Bryant, R. V., Holloway, R. H., & Nguyen, N. Q. (2012). Gastrointestinal: role of endoscopic ultrasound in the evaluation of pseudoachalasia. Journal of Gastroenterology and Hepatology, 27(6), 1128.
    DOI Scopus8 WoS6 Europe PMC3
    2011 Bryant, R. V., Schoeman, S. N., & Schoeman, M. N. (2011). Split vs single day preparation and colonoscopy outcomes in a large single Australian centre. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, 75.
    2011 Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923.
    DOI Scopus76 WoS63 Europe PMC54
    2010 Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703.
    DOI Scopus3 WoS2

  • Book Chapters
    Year Citation
    2024 Higgins, D., & Perkins, H. (2024). Forensic Odontology. In Forensic and Legal Medicine: Clinical and Pathological Aspects (pp. 889-894). CRC Press.
    DOI
    2019 Gill, M., & Bryant, R. V. (2019). Inflammatory Bowel Disease: Diagnosis and Management. In Gastroenterology For General Surgeons (pp. 55-73). Springer International Publishing.
    DOI

  • Conference Papers
    Year Citation
    2024 Goodsall, T. M., Day, A. S., Andrews, J. M., Ruszkiewicz, A., Ma, C., & Bryant, R. V. (2024). Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study. In Inflammatory Bowel Diseases Vol. 30 (pp. 190-195). England: OXFORD UNIV PRESS INC.
    DOI Scopus10 WoS4 Europe PMC4
    2023 Schubert, J., Tay, A., Lee, K. H. C., Leong, L., Rayner, C., Warner, W., . . . Bryant, R. (2023). Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence mutations. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 221). Australia: WILEY.
    DOI
    2022 Tucker, E., Haylock-Jacobs, S., Bryant, R. V., & Costello, S. (2022). Stool donor screening eligibility and retention with a Therapeutic Goods Order 105-compliant stool donor screening program for fecal microbiota transplantation. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 208). WILEY.
    2022 Whitfield, H. J., Berthelet, J., Mangiola, S., Bell, C., Anderson, R. L., Pal, B., . . . Davis, M. J. (2022). Defining the cellular composition and associated molecular phenotypes of malignant and non-malignant cells in breast cancer pleural effusions. In CANCER RESEARCH Vol. 82 (pp. 2 pages). LA, New Orleans: AMER ASSOC CANCER RESEARCH.
    2022 An, Y. -K., Khoo, E., Lindsay, N., Amiss, A., Fernandes, R., Thin, L., . . . Begun, J. (2022). Gastrointestinal ultrasound predicts need for rescue therapy in a multicenter prospective cohort of patients with acute severe ulcerative colitis: USUC study, including the GENIUS cohort. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 147). WILEY.
    2022 Plush, S., Broad, L., Bryant, R. V., Shin, S. H., Kumar, S., & Day, A. (2022). Most referrals for functional gastrointestinal disorders are inadequate: Findings from a clinical audit of a tertiary gastroenterology service waitlist. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 200). WILEY.
    2021 Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., & Bryant, R. V. (2021). Geospatial analysis of Helicobacter pylori infection in the Greater Adelaide region over 20 years: Should location influence choice of eradication therapy?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 137-138). Virtual online: WILEY.
    2020 Haram, N., Ivanov, I., Xu, H., Kim, K. T., Atia-Tul-Noor, A., Sainadh, U. S., . . . Sang, R. T. (2020). Disentangling relativistic non-dipole effects in strong field atomic ionisation in non-relativistic regime. In Journal of Physics: Conference Series Vol. 1412 (pp. 092003). FRANCE, Deauville: IOP Publishing.
    DOI
    2006 Lu, J., Tian, W., Liu, L., & Zhang, F. (2006). The anti-vibrating-impact research of the piezoelectric resonator force sensor. In RARE METAL MATERIALS AND ENGINEERING Vol. 35 (pp. 625-626). PEOPLES R CHINA, Guillin: NORTHWEST INST NONFERROUS METAL RESEARCH.

  • Conference Items
    Year Citation
    2018 Rajagopalan, A., Sathananthan, D., Van De Ven, L., Martin, S., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Acceptability, tolerability, and impact on illness-related knowledge. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2018 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2016 Bryant, R. V., Costello, S. C., Schoeman, S., Sathananthan, D., Lau, S. Y., Schoeman, M. N., . . . Andrews, J. M. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
    2016 Bryant, R. V., Costello, S. C., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. M. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
    2015 Pilichiewicz, A. N., Goess, C., Linedale, E., Ooi, S. J., Bryant, R. V., Grafton, R., . . . Andrews, J. M. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of Abstracts of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley.
    DOI
    2014 Bryant, R. V., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. M. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2014 Lim, A. H., Ooi, S. Y., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., . . . Andrews, J. M. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley.
    DOI
    2012 Nguyen, N. Q., Bryant, R. V., Kuo, P., Williamson, K. D., Schoeman, M., & Holloway, R. H. (2012). Risk Stratification With Glasgow-Blatchford Bleeding Score for Hospitalized Patients With Upper Gastrointestinal Bleeding Can Avoid the Needs for Urgent Endo-Therapy. Poster session presented at the meeting of GASTROINTESTINAL ENDOSCOPY. San Diego, CA: MOSBY-ELSEVIER.
    WoS2
    2012 Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley.
    DOI

  • Preprint
    Year Citation
    2023 Subramanian, S., Subramanian, S., Thoms, J. A. I., Huang, Y., Cornejo, P., Koch, F., . . . Pimanda, J. (2023). Cell Type-Specific Regulation by a Heptad of Transcription Factors in Human Hematopoietic Stem and Progenitor Cells.
    DOI
    2023 Lazniewska, J., Li, K. L., Johnson, I., Sorvina, A., Logan, J., Martini, C., . . . Brooks, D. (2023). Dynamic interplay between sortilin and syndecan-1 drives a metabolic switch during prostate cancer progression.
    DOI
    2021 Dinevska, M., Widodo, S., Furst, L., Cuzcano, L., Fang, Y., Mangiola, S., . . . Mantamadiotis, T. (2021). Tissue remodeling and cell signaling underpin changes in tumor microenvironment heterogeneity in glioma oncogenesis.
    DOI

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2024 Principal Supervisor Microbial manipulation as treatment for primary sclerosing cholangitis Doctor of Philosophy Doctorate Full Time Dr Damjana Bogatic
    2024 Principal Supervisor Exploring the use of exclusive enteral nutrition in adult patients with Crohn's disease Doctor of Philosophy Doctorate Full Time Dr Matthew Chu
    2023 Principal Supervisor Intestinal ultrasound as a novel tool to assess luminal contents in inflammatory and functional gastrointestinal disorders Doctor of Philosophy Doctorate Full Time Dr Ryan Mathias
    2023 Co-Supervisor Faecal Microbiota Transplant (FMT) as a safe and efficacious therapeutic alternative for refractory proctitis Doctor of Philosophy Doctorate Full Time Dr Sreecanth Raja
    2023 Principal Supervisor Evaluating the inflammatory potential of dietary protein in inflammatory bowel disease Doctor of Philosophy Doctorate Full Time Miss Rachel Hannah Davis
    2022 Principal Supervisor Dietitian-first services: application of extended scope dietetics within gastroenterology services. Doctor of Philosophy Doctorate Full Time Miss Samantha Plush

  • Past Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2021 - 2024 Co-Supervisor Improving treatment outcomes and prognosticating gastric cancer risk in patients with Helicobacter pylori infection Doctor of Philosophy Doctorate Full Time Mr Jonathon Paul Schubert
    2021 - 2024 Co-Supervisor Defining and validating the role of intestinal ultrasound for assessment of inflammatory bowel disease Doctor of Philosophy Doctorate Full Time Dr Tom Goodsall
    2018 - 2021 Co-Supervisor Exploring a patient-centred, diet-focused treatment paradigm for Inflammatory Bowel Disease Doctor of Philosophy Doctorate Full Time Mrs Alice Sarah Day

  • Other Supervision Activities
    Date Role Research Topic Location Program Supervision Type Student Load Student Name
    2018 - ongoing Principal Supervisor Dietetic Flinders University - Honours - Rachel Davis
    2018 - ongoing Principal Supervisor Gastroenterology Advanced Training Research Project University of Adelaide - Other - Dr Arvind Rajagopalan

  • Committee Memberships
    Date Role Committee Institution Country
    2021 - ongoing Chair Executive Committee Gastroenterology Network of Intestinal Ultrasound (GENIUS) Australia
    2019 - ongoing Member IBD Faculty Gastroenterological Society of Australia Australia
    2014 - ongoing Member Conjoint Committee Recognition of Training Gastrointestinal Endoscopy, Upper Endoscopy and Colonoscopy, Gastroenterological Society of Australia (GESA) Gastroenterological Society of Australia (GESA) Australia

  • Memberships
    Date Role Membership Country
    2015 - ongoing Member Crohn’s Colitis Foundation Australia
    2013 - ongoing Member European Crohn’s and Colitis Organisation Denmark
    2013 - ongoing Member British Society of Gastroenterology Ukraine
    2012 - ongoing Member American Gastroenterology Association United States
    2011 - ongoing Member Gastroenterological Society of Australia Australia
    2010 - ongoing Member Royal Australasian College of Physicians Australia
    2008 - 2012 Member Royal Adelaide Hospital Resident Medical Officers Association Australia

  • Industry Partnerships
    Date Engagement Type Partner Name
    2023 - ongoing Consultant BiomeBank
Connect With Me
External Profiles